FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

38112003: 1 (qualifier value)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    1 Is a General adjectival modifier false Inferred relationship Some
    1 Is a Number false Inferred relationship Some

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Amoxicillin (as amoxicillin sodium) 1 g powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Amoxicillin (as amoxicillin sodium) 1 g powder for solution for injection vial Has presentation strength numerator value False 1 Inferred relationship Some 1
    Mitomycin 20 mg powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Mitomycin 20 mg powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Fludarabine phosphate 50 mg powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Fludarabine phosphate 50 mg powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Mycophenolate mofetil (as mycophenolate mofetil hydrochloride) 500 mg powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Mycophenolate mofetil (as mycophenolate mofetil hydrochloride) 500 mg powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely indometacin 5 milligram/1 milliliter conventional release oral suspension (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely idarubicin hydrochloride 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely idarubicin hydrochloride 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Chlorpromazine hydrochloride 5 mg/mL oral solution Count of base of active ingredient False 1 Inferred relationship Some
    Ifosfamide 1 g powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Ifosfamide 1 g powder for solution for injection vial Has presentation strength numerator value False 1 Inferred relationship Some 1
    Ifosfamide 1 g powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely pantoprazole (as pantoprazole sodium sesquihydrate) 40 milligram/1 vial powder for conventional release solution for injection Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely pantoprazole (as pantoprazole sodium sesquihydrate) 40 milligram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 1 Inferred relationship Some
    Lanreotide (as lanreotide acetate) 30 mg powder for suspension for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Lanreotide (as lanreotide acetate) 30 mg powder for suspension for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely idarubicin hydrochloride 10 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely idarubicin hydrochloride 10 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Ifosfamide 2 g powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Ifosfamide 2 g powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely lenograstim 13.4 million unit/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely lenograstim 13.4 million unit/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely clonazepam 100 microgram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely remifentanil (as remifentanil hydrochloride) 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely remifentanil (as remifentanil hydrochloride) 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Liothyronine sodium 20 microgram powder for solution for injection ampule Count of base of active ingredient False 1 Inferred relationship Some
    Liothyronine sodium 20 microgram powder for solution for injection ampule Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely piperacillin (as piperacillin sodium) 4 gram and tazobactam (as tazobactam sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely piperacillin (as piperacillin sodium) 4 gram and tazobactam (as tazobactam sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 2
    Product containing precisely thiopental sodium 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely thiopental sodium 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely melphalan (as melphalan hydrochloride) 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely melphalan (as melphalan hydrochloride) 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely sodium nitroprusside dihydrate 50 milligram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely sodium nitroprusside dihydrate 50 milligram/1 vial powder for conventional release solution for injection Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely octreotide (as octreotide acetate) 10 milligram/1 vial powder for conventional release suspension for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely octreotide (as octreotide acetate) 10 milligram/1 vial powder for conventional release suspension for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Leuprorelin acetate 11.25 mg powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Leuprorelin acetate 11.25 mg powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely cyanocobalamin 7 microgram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely octreotide (as octreotide acetate) 20 milligram/1 vial powder for conventional release suspension for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely octreotide (as octreotide acetate) 20 milligram/1 vial powder for conventional release suspension for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Leuprorelin acetate 3.75 mg powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Leuprorelin acetate 3.75 mg powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Topotecan (as topotecan hydrochloride) 4 mg powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Topotecan (as topotecan hydrochloride) 4 mg powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely vancomycin (as vancomycin hydrochloride) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely vancomycin (as vancomycin hydrochloride) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely vindesine sulfate 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely vindesine sulfate 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely omeprazole (as omeprazole sodium) 40 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely omeprazole (as omeprazole sodium) 40 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely palivizumab 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely palivizumab 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely porfimer sodium 75 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely porfimer sodium 75 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Palivizumab 50 mg powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Palivizumab 50 mg powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely peginterferon alfa-2b 100 microgram/1 vial powder for conventional release solution for injection Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely peginterferon alfa-2b 100 microgram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 1 Inferred relationship Some
    Treosulfan 5 g powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Treosulfan 5 g powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely nabumetone 100 milligram/1 milliliter conventional release oral suspension (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely vecuronium bromide 10 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely vecuronium bromide 10 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely flucloxacillin (as flucloxacillin sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely flucloxacillin (as flucloxacillin sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely meropenem (as meropenem trihydrate) 1 gram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely meropenem (as meropenem trihydrate) 1 gram/1 vial powder for conventional release solution for injection Has presentation strength numerator value False 1 Inferred relationship Some 1
    Product containing precisely meropenem (as meropenem trihydrate) 1 gram/1 vial powder for conventional release solution for injection Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely furosemide 10 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely micafungin (as micafungin sodium) 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely micafungin (as micafungin sodium) 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Vinblastine sulfate 10 mg powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Vinblastine sulfate 10 mg powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Sodium valproate 400 mg powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Sodium valproate 400 mg powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Flucloxacillin (as flucloxacillin sodium) 1 g powder for solution for injection vial Has presentation strength numerator value False 1 Inferred relationship Some 1
    Flucloxacillin (as flucloxacillin sodium) 1 g powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Flucloxacillin (as flucloxacillin sodium) 1 g powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Prednisolone 3 mg/mL oral solution Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely secretin 16 microgram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely secretin 16 microgram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Pentamidine isetionate 300 mg powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Pentamidine isetionate 300 mg powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely rasburicase 1.5 milligram/1 vial powder for conventional release solution for injection Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely rasburicase 1.5 milligram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely erythromycin (as erythromycin lactobionate) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely erythromycin (as erythromycin lactobionate) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely erythromycin (as erythromycin lactobionate) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator value False 1 Inferred relationship Some 1
    Streptomycin (as streptomycin sulfate) 1 g powder for solution for injection vial Has presentation strength numerator value False 1 Inferred relationship Some 1
    Streptomycin (as streptomycin sulfate) 1 g powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Streptomycin (as streptomycin sulfate) 1 g powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Vancomycin (as vancomycin hydrochloride) 1 g powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Vancomycin (as vancomycin hydrochloride) 1 g powder for solution for injection vial Has presentation strength numerator value False 1 Inferred relationship Some 1
    Vancomycin (as vancomycin hydrochloride) 1 g powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely voriconazole 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely voriconazole 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1

    Start Previous Page 70 of 215 Next End


    Reference Sets

    Concept inactivation indicator reference set

    Back to Start